Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Lymphoma 8Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Hodgkin Disease 6Recurrence 3Kidney Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Teratoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1HIV Infections 1Carcinoma, Renal Cell 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Cisplatin 12Pemetrexed 6Radiotherapy 5Platinum 4Doxorubicin 41,2-diaminocyclohexaneplatinum II citrate 4cediranib 3Mitomycin 3Gemcitabine 3Decitabine 3pembrolizumab 2Vinorelbine 2SS1(dsFv)PE38 2Interferon-gamma 2Gene Expression Profiling 2Erlotinib Hydrochloride 2Depsipeptides 2Cyclophosphamide 2Celecoxib 2sargramostim 1rilotumumab 1ranpirnase 1methoxyamine 1entinostat 1decitabine and cedazuridine drug combination 1cixutumumab 1belinostat 1atezolizumab 1anetumab ravtansine 1alvocidib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Mesothelioma, Malignant × Vinblastine × Clear all
NCT00030459 2013-08-07

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 2 Unknown
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡